Altered renal microvascular response in Zucker obese rats

Koichi Hayashi, Takeshi Kanda, Koichiro Honma, Hirobumi Tokuyama, Ken Okubo, Ichiro Takamatsu, Satoru Tatematsu, Hiroo Kumagai, Takao Saruta

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Although available evidence demonstrates that obesity manifests insulin resistance and causes glomerular sclerosis, it has not been determined whether insulin resistance alters the renal microvascular reactivity. This study examined whether insulin- and acetylcholine (ACH)-induced vasodilation was impaired in Zucker obese rats, and attempted to clarify the change in myogenic afferent arteriolar constriction, a determinant of glomerular pressure. Isolated perfused hydronephrotic rat kidneys were used to visualize the renal microcirculation. In Zucker lean rats, insulin (10 to 300 μU/mL) inhibited norepinephrine (NE)-induced afferent and efferent arteriolar constriction in a dose-dependent manner, with 112% ± 8% and 98% ± 8% reversal at 300 μU/mL Similarly, ACH elicited dose-dependent dilation of these vessels. In Zucker obese rats, by contrast, afferent and efferent arterioles failed to dilate in response to insulin, and manifested diminished vasodilator responses to acetylcholine. In the presence of nitro-L-arginine methylester (LNAME; 100 μmol/L), ACH (10 μmol/L) induced transient afferent arteriolar dilation (121% ± 9% reversal) in Zucker lean rats, whereas this response was blunted in obese rats (72% ± 8% reversal). Furthermore, myogenic afferent arteriolar constriction by elevating renal arterial pressure to 180 mm Hg was diminished in Zucker obese rats (-14% ± 3% decrement in diameter), compared with that in lean rats (-23% ± 2% decrement). Finally, the impairment in these vasodilator and vasoconstrictor responses was partially prevented by troglitazone, an insulin-sensitizing agent. Collectively, in insulin resistance, renal microvessels are refractory to the vasodilator action of insulin. Furthermore, "renal insulin resistance" is associated with the impaired vasodilator responses to ACH-induced nitric oxide (NO) and the diminished vasoconstrictor responses to pressure. The blunted myogenic afferent arteriolar constriction would allow glomerular hypertension, and in concert with the impaired endothelium-dependent vasodilation, could be responsible for the development of glomerular injury in obesity.

Original languageEnglish
Pages (from-to)1553-1561
Number of pages9
JournalMetabolism: Clinical and Experimental
Volume51
Issue number12
DOIs
Publication statusPublished - 2002 Dec 1

Fingerprint

Zucker Rats
Acetylcholine
Vasodilator Agents
Kidney
Constriction
Insulin Resistance
Insulin
troglitazone
Vasoconstrictor Agents
Vasodilation
Dilatation
Obesity
Pressure
Arterioles
Sclerosis
Microcirculation
Microvessels
Endothelium
Arginine
Norepinephrine

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Altered renal microvascular response in Zucker obese rats. / Hayashi, Koichi; Kanda, Takeshi; Honma, Koichiro; Tokuyama, Hirobumi; Okubo, Ken; Takamatsu, Ichiro; Tatematsu, Satoru; Kumagai, Hiroo; Saruta, Takao.

In: Metabolism: Clinical and Experimental, Vol. 51, No. 12, 01.12.2002, p. 1553-1561.

Research output: Contribution to journalArticle

Hayashi, K, Kanda, T, Honma, K, Tokuyama, H, Okubo, K, Takamatsu, I, Tatematsu, S, Kumagai, H & Saruta, T 2002, 'Altered renal microvascular response in Zucker obese rats', Metabolism: Clinical and Experimental, vol. 51, no. 12, pp. 1553-1561. https://doi.org/10.1053/meta.2002.36311
Hayashi, Koichi ; Kanda, Takeshi ; Honma, Koichiro ; Tokuyama, Hirobumi ; Okubo, Ken ; Takamatsu, Ichiro ; Tatematsu, Satoru ; Kumagai, Hiroo ; Saruta, Takao. / Altered renal microvascular response in Zucker obese rats. In: Metabolism: Clinical and Experimental. 2002 ; Vol. 51, No. 12. pp. 1553-1561.
@article{eccacf104c7d40c28c0a09b160d31580,
title = "Altered renal microvascular response in Zucker obese rats",
abstract = "Although available evidence demonstrates that obesity manifests insulin resistance and causes glomerular sclerosis, it has not been determined whether insulin resistance alters the renal microvascular reactivity. This study examined whether insulin- and acetylcholine (ACH)-induced vasodilation was impaired in Zucker obese rats, and attempted to clarify the change in myogenic afferent arteriolar constriction, a determinant of glomerular pressure. Isolated perfused hydronephrotic rat kidneys were used to visualize the renal microcirculation. In Zucker lean rats, insulin (10 to 300 μU/mL) inhibited norepinephrine (NE)-induced afferent and efferent arteriolar constriction in a dose-dependent manner, with 112{\%} ± 8{\%} and 98{\%} ± 8{\%} reversal at 300 μU/mL Similarly, ACH elicited dose-dependent dilation of these vessels. In Zucker obese rats, by contrast, afferent and efferent arterioles failed to dilate in response to insulin, and manifested diminished vasodilator responses to acetylcholine. In the presence of nitro-L-arginine methylester (LNAME; 100 μmol/L), ACH (10 μmol/L) induced transient afferent arteriolar dilation (121{\%} ± 9{\%} reversal) in Zucker lean rats, whereas this response was blunted in obese rats (72{\%} ± 8{\%} reversal). Furthermore, myogenic afferent arteriolar constriction by elevating renal arterial pressure to 180 mm Hg was diminished in Zucker obese rats (-14{\%} ± 3{\%} decrement in diameter), compared with that in lean rats (-23{\%} ± 2{\%} decrement). Finally, the impairment in these vasodilator and vasoconstrictor responses was partially prevented by troglitazone, an insulin-sensitizing agent. Collectively, in insulin resistance, renal microvessels are refractory to the vasodilator action of insulin. Furthermore, {"}renal insulin resistance{"} is associated with the impaired vasodilator responses to ACH-induced nitric oxide (NO) and the diminished vasoconstrictor responses to pressure. The blunted myogenic afferent arteriolar constriction would allow glomerular hypertension, and in concert with the impaired endothelium-dependent vasodilation, could be responsible for the development of glomerular injury in obesity.",
author = "Koichi Hayashi and Takeshi Kanda and Koichiro Honma and Hirobumi Tokuyama and Ken Okubo and Ichiro Takamatsu and Satoru Tatematsu and Hiroo Kumagai and Takao Saruta",
year = "2002",
month = "12",
day = "1",
doi = "10.1053/meta.2002.36311",
language = "English",
volume = "51",
pages = "1553--1561",
journal = "Metabolism: Clinical and Experimental",
issn = "0026-0495",
publisher = "W.B. Saunders Ltd",
number = "12",

}

TY - JOUR

T1 - Altered renal microvascular response in Zucker obese rats

AU - Hayashi, Koichi

AU - Kanda, Takeshi

AU - Honma, Koichiro

AU - Tokuyama, Hirobumi

AU - Okubo, Ken

AU - Takamatsu, Ichiro

AU - Tatematsu, Satoru

AU - Kumagai, Hiroo

AU - Saruta, Takao

PY - 2002/12/1

Y1 - 2002/12/1

N2 - Although available evidence demonstrates that obesity manifests insulin resistance and causes glomerular sclerosis, it has not been determined whether insulin resistance alters the renal microvascular reactivity. This study examined whether insulin- and acetylcholine (ACH)-induced vasodilation was impaired in Zucker obese rats, and attempted to clarify the change in myogenic afferent arteriolar constriction, a determinant of glomerular pressure. Isolated perfused hydronephrotic rat kidneys were used to visualize the renal microcirculation. In Zucker lean rats, insulin (10 to 300 μU/mL) inhibited norepinephrine (NE)-induced afferent and efferent arteriolar constriction in a dose-dependent manner, with 112% ± 8% and 98% ± 8% reversal at 300 μU/mL Similarly, ACH elicited dose-dependent dilation of these vessels. In Zucker obese rats, by contrast, afferent and efferent arterioles failed to dilate in response to insulin, and manifested diminished vasodilator responses to acetylcholine. In the presence of nitro-L-arginine methylester (LNAME; 100 μmol/L), ACH (10 μmol/L) induced transient afferent arteriolar dilation (121% ± 9% reversal) in Zucker lean rats, whereas this response was blunted in obese rats (72% ± 8% reversal). Furthermore, myogenic afferent arteriolar constriction by elevating renal arterial pressure to 180 mm Hg was diminished in Zucker obese rats (-14% ± 3% decrement in diameter), compared with that in lean rats (-23% ± 2% decrement). Finally, the impairment in these vasodilator and vasoconstrictor responses was partially prevented by troglitazone, an insulin-sensitizing agent. Collectively, in insulin resistance, renal microvessels are refractory to the vasodilator action of insulin. Furthermore, "renal insulin resistance" is associated with the impaired vasodilator responses to ACH-induced nitric oxide (NO) and the diminished vasoconstrictor responses to pressure. The blunted myogenic afferent arteriolar constriction would allow glomerular hypertension, and in concert with the impaired endothelium-dependent vasodilation, could be responsible for the development of glomerular injury in obesity.

AB - Although available evidence demonstrates that obesity manifests insulin resistance and causes glomerular sclerosis, it has not been determined whether insulin resistance alters the renal microvascular reactivity. This study examined whether insulin- and acetylcholine (ACH)-induced vasodilation was impaired in Zucker obese rats, and attempted to clarify the change in myogenic afferent arteriolar constriction, a determinant of glomerular pressure. Isolated perfused hydronephrotic rat kidneys were used to visualize the renal microcirculation. In Zucker lean rats, insulin (10 to 300 μU/mL) inhibited norepinephrine (NE)-induced afferent and efferent arteriolar constriction in a dose-dependent manner, with 112% ± 8% and 98% ± 8% reversal at 300 μU/mL Similarly, ACH elicited dose-dependent dilation of these vessels. In Zucker obese rats, by contrast, afferent and efferent arterioles failed to dilate in response to insulin, and manifested diminished vasodilator responses to acetylcholine. In the presence of nitro-L-arginine methylester (LNAME; 100 μmol/L), ACH (10 μmol/L) induced transient afferent arteriolar dilation (121% ± 9% reversal) in Zucker lean rats, whereas this response was blunted in obese rats (72% ± 8% reversal). Furthermore, myogenic afferent arteriolar constriction by elevating renal arterial pressure to 180 mm Hg was diminished in Zucker obese rats (-14% ± 3% decrement in diameter), compared with that in lean rats (-23% ± 2% decrement). Finally, the impairment in these vasodilator and vasoconstrictor responses was partially prevented by troglitazone, an insulin-sensitizing agent. Collectively, in insulin resistance, renal microvessels are refractory to the vasodilator action of insulin. Furthermore, "renal insulin resistance" is associated with the impaired vasodilator responses to ACH-induced nitric oxide (NO) and the diminished vasoconstrictor responses to pressure. The blunted myogenic afferent arteriolar constriction would allow glomerular hypertension, and in concert with the impaired endothelium-dependent vasodilation, could be responsible for the development of glomerular injury in obesity.

UR - http://www.scopus.com/inward/record.url?scp=0036918348&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036918348&partnerID=8YFLogxK

U2 - 10.1053/meta.2002.36311

DO - 10.1053/meta.2002.36311

M3 - Article

C2 - 12489067

AN - SCOPUS:0036918348

VL - 51

SP - 1553

EP - 1561

JO - Metabolism: Clinical and Experimental

JF - Metabolism: Clinical and Experimental

SN - 0026-0495

IS - 12

ER -